1. Germany Stocks

  2. •

    Health services

  3. •

    Medical/Nursing services
M1 Kliniken AG

M1 Kliniken AG

19.64
EUR
+0.32
(+1.66%)
338.38MMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.53
2.33
2.4
3.07
3.88
4.41
8.59
16.02
14.52
16.1
17.27
18.55
- -
Basic EPS, GAAP
0.31
0.44
0.33
0.38
0.39
0.56
0.37
0.45
0.22
0.52
0.82
1.13
- -
Free Cash Flow per Basic Share
- -
- -
0.46
-0.09
0.03
-0.38
0.44
0.73
0.97
0.35
1.48
1.93
- -
Dividend per Share
- -
- -
0.3
0.29
0.29
0.3
0.01
0.08
0.09
0.1
0.47
0.47
- -
Book Value per Share
1.69
1.98
2.02
2.87
3.64
3.9
4.62
5.11
5.22
5.92
5.65
6.39
6.39
Tangible Book Value per Share
0.76
1.45
1.47
2.37
3.17
3.42
2.55
1.86
1.92
1.35
0.99
1.58
1.58
Basic Weighted Avg Shares
15
15
15
15
17
18
19
20
20
20
20
20
19
Sales/Revenue/Turnover
23
35
36
47
65
77
160
315
285
316
339
364
- -
Operating Margin (%)
6.29
18.81
12.14
12.09
9.81
10.12
5.94
3.86
3.14
4.63
7.7
10.09
- -
Depreciation Expense
- -
- -
- -
- -
1
3
4
6
6
5
5
5
- -
Net Income, GAAP
5
7
5
6
7
10
7
9
4
10
16
22
- -
Effective Tax Rate (%)
5.07
2.07
8.76
21.43
18.31
23.66
15.41
24.57
30.91
29.06
32.35
29.25
- -
Profit Margin (%)
19.92
18.99
13.93
12.24
10.14
12.6
4.28
2.83
1.51
3.25
4.72
6.08
- -
Working Capital
-3
16
15
26
39
45
64
67
70
52
40
58
58
LT Debt
1
- -
- -
- -
- -
9
9
8
10
8
7
5
5
Total Equity
25
30
30
47
64
68
115
140
143
143
134
150
150
Return on Invested Capital (%)
- -
23.94
13.14
11.35
9.29
8.3
3.57
6.49
4.13
6.98
11.62
15.6
- -
Return on Capital (%)
- -
24.12
16.72
14.88
11.9
13.95
6.61
5.46
1.39
6.33
10.41
14.08
- -
Return on Common Equity (%)
- -
24.05
16.69
14.9
11.91
14.74
8.86
9.85
4.53
9.84
14.61
19.58
- -

Capital Structure

EUR

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
ST Debt
3
3
2
LT Borrowings
- -
- -
- -
LT Finance Leases
7
6
5
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
19
19
19
Market Capitalization
297
278
338

Working Capital

EUR

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
Total Current Assets
84
97
89
Cash, Cash Equivalents & STI
24
46
47
Accounts Receivable, Net
16
11
6
Inventories
36
34
32
Total Current Liabilities
44
47
32
Payables & Accruals
- -
- -
- -
ST Debt
3
3
2
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
19.8%
5.83%
11.77%
Free Cash Flow
797.99%
80.5%
30.43%
Net Income, GAAP
23.37%
42.21%
38.17%
Sales/Revenue/Turnover
31.08%
22.67%
7.4%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
316
2024
- -
- -
339
2025
- -
- -
364

Semi-annual Earnings Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
0.52
2024
- -
- -
0.82
2025
- -
- -
1.13

Semi-annual Dividends Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
0.1
2024
- -
- -
0.47
2025
- -
- -
0.47

Company Description

Company Profile APIChatGPT
CEO
Attila Strauss
Full Time Employees
280
Sector
Health services
Industry
Medical/Nursing services
Address
Grünauer Strasse 5 Berlin BE Germany 12557
IPO Date
Sep 14, 2015
Website
m1-kliniken.de
Similar Companies
Hims & Hers Health, Inc. (NYSE:HIMS)
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
Mobile-health Network Solutions (NASDAQ:MNDR)
Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
Tenon Medical, Inc. (NASDAQ:TNON)
Teladoc Health, Inc. (NYSE:TDOC)
Business
M1 Kliniken AG, a Germany-based operator of healthcare facilities focused on aesthetic medicine and plastic surgery, provides a range of beauty medical treatments and services through its Beauty segment, including breast augmentation, eyelid lifts, liposuction, abdominoplasty, nose corrections, face lifts, upper arm and thigh lifts, labia corrections, wrinkle treatments, lip treatments, and injections with hyaluronic acid and botulinum toxin; it also operates specialist centers under the M1 Med Beauty brand at more than 35 locations across Germany, as well as the M1 Schlossklinik in Berlin, one of Europe's largest facilities for plastic and aesthetic surgery with six operating theaters and 35 beds. Through its Trade segment, the company sells pharmaceuticals and medical products for therapeutic areas such as oncology, HIV/AIDS, neurology, rheumatology, chronic diseases, and aesthetic medicine. M1 Kliniken AG markets high-quality products under the M1 Select and M1 Aesthetics brands to private customers, doctors, pharmacies, and wholesalers; it conducts operations in Germany, Austria, Switzerland, the Netherlands, the United Kingdom, and Australia, targeting price-sensitive consumers seeking high-quality aesthetic procedures. Founded in 2007 and headquartered at Gruenauer Strasse 5 in Berlin, Germany, the company functions as a subsidiary of MPH Health Care AG and employs over 350 staff, performing more than 400,000 minimally invasive and surgical procedures annually with specialized doctors trained at the M1 Akademie. In recent developments, M1 Kliniken AG formerly known as M1 Beauty AG reports strong financial performance in the first half of 2025 with group revenue up 9.4% to EUR 183.5 million, EBIT growth of 24% driven by efficiency measures and capacity expansions in the Beauty segment, alongside a sustained share buyback program initiated in April 2024 extending through April 2025 involving up to 1 million shares; the company pursues ongoing clinic network expansion and international growth while exploring strategic options for its Trade segment, including early-stage investor interest.